[The dependence of the efficacy of cyclosporin A use in a kidney allograft on the degree of donor and recipient tissue compatibility based on HLA-DR antigens].
Upon the analyses of outcomes of 69 primary allogenic kidney transplantations it was noted that cyclosporin A immunosuppressive potential grew in transplantation of the kidney more compatible by HLA-DR antigens. It follows that it would be valid to perform tissue selection in the above use of the drug cyclosporin A.
Abramov
V Iu
VIu
Kaluzhina
N N
NN
Otocheva
L V
LV
Zaretskaia
Iu M
IuM
D016572:Cyclosporine / Q000627:therapeutic use*; D006085:Graft Survival / Q000187:drug effects / Q000276:immunology; D006684:HLA-DR Antigens / Q000097:blood*; D006648:Histocompatibility / Q000276:immunology*; D006801:Humans; D007165:Immunosuppression Therapy / Q000379:methods; D016030:Kidney Transplantation / Q000276:immunology*; D014019:Tissue Donors; D014184:Transplantation, Homologous; D016896:Treatment Outcome
D006684:HLA-DR Antigens; D016572:Cyclosporine
Zavisimost' éffektivnosti primeneniia tsiklosporina A pri allotransplantatsii pochki ot stepeni tkanevoĭ sovmestimosti donora i retsipienta po antigenam HLA-DR.